Unbiased clustering approach facilitates the VUS Classification in a Patient with CTLA-4 Haploinsufficiency

被引：0
|
作者：
Fernandez, Isabel [1 ]
Starich, Olivia [2 ]
Ehler, Angelica [3 ]
Bruckner, Anna [3 ]
Shirley, Joel [3 ]
Knight, Vijaya [3 ]
Abbott, Jordan [3 ]
机构：
[1] Univ Colorado, Anschutz, Boulder, CO USA
[2] Univ Colorado, Sch Med, Boulder, CO 80309 USA
[3] Univ Colorado, Sch Med, Childrens Hosp Colorado, Boulder, CO USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2022年 / 42卷 / SUPPL 1期
关键词：
CTLA-4; primary immunodeficiency; AIRE; clustering;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
167
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 21 条
  • [11] CTLA-4 inhibition facilitates follicular T and B cell interaction and the production of tumor-specific antibodies
    Jo, Areum
    Jeong, Dasom
    Eum, Hye Hyeon
    Kim, Nayoung
    Na, Minsu
    Kang, Huiram
    Lee, Hae-Ock
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (09) : 1964 - 1976
  • [12] Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency
    Nishimura, Masashi
    Miyata, Jun
    Tanigaki, Tomomi
    Nomura, Sakika
    Serizawa, Yusuke
    Igarashi, Syunya
    Itou, Koki
    Ohno, Tomohiro
    Kurata, Yuhei
    Kimizuka, Yoshifumi
    Fujikura, Yuji
    Sekinaka, Yujin
    Sekinaka, Kanako
    Matsukuma, Susumu
    Nonoyama, Shigeaki
    Kawana, Akihiko
    INTERNAL MEDICINE, 2023, 62 (06) : 871 - 875
  • [13] Blockade of PD-1 and CTLA-4: A potent immunotherapeutic approach for hepatocellular carcinoma
    Hou, Kai
    Xu, Xiaohui
    Ge, Xin
    Jiang, Jiacen
    Ouyang, Fan
    BIOFACTORS, 2024, 50 (02) : 250 - 265
  • [14] Case report: Pediatric patient with severe clinical course of CTLA-4 insufficiency treated with HSCT
    Drabko, Katarzyna
    Zarychta, Julia
    Kowalczyk, Adrian
    Cienkusz, Magdalena
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [15] CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis
    Fedele, A. L.
    Alivernini, S.
    Gremese, E.
    Ferraccioli, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 315 - 317
  • [16] Single versus combined immunoregulatory approach using PD-1 and CTLA-4 modulators in controlling sepsis
    Rudick, Courtney P.
    Cornell, David L.
    Agrawal, Devendra K.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (09) : 907 - 919
  • [17] Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion
    Lougaris, Vassilios
    Malagola, Michele
    Baronio, Manuela
    Morello, Enrico
    Gazzurelli, Luisa
    Benvenuto, Alessio
    Palumbo, Laura
    Moratto, Daniele
    Girelli, Maria Federica
    Chiarini, Marcho
    Meini, Antonella
    Turra, Alessandro
    Bernardi, Simona
    Polverelli, Nicola
    Russo, Domenico
    Plebani, Alessandro
    CLINICAL IMMUNOLOGY, 2020, 220
  • [18] Design of a novel multiepitope vaccine with CTLA-4 extracellular domain against Mycoplasma pneumoniae: A vaccine-immunoinformatics approach
    Pan, Xiaohong
    Guo, Xiaomei
    Shi, Jiandong
    VACCINE, 2024, 42 (18) : 3883 - 3898
  • [19] Efficacy and Safety of AK104, an Anti-PD-1/CTLA-4 Bispecific Antibody, in a Patient with Large Cell Neuroendocrine Carcinoma of the Lung
    Frentzas, S.
    Kwek, K. Y.
    Konpa, A.
    Jin, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S506 - S506
  • [20] CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
    Erna-Elise Paulsen
    Thomas K. Kilvaer
    Mehrdad Rakaee
    Elin Richardsen
    Sigurd M. Hald
    Sigve Andersen
    Lill-Tove Busund
    Roy M. Bremnes
    Tom Donnem
    Cancer Immunology, Immunotherapy, 2017, 66 : 1449 - 1461
123